S

Global biopharmaceutical company focused on rare-disease treatments; acquired by Takeda in 2018. Its Shire Strategic Investment Group made biotech venture investments.

Dublin, Ireland · 2+ investments · 2 portfolio companies

Biotech
Healthcare
Headquarters
Dublin, Ireland
Founded
1986
Portfolio Companies
2
Total Investments
2
Last Investment
Dec 2012

Investment Thesis

Shire Strategic Investment Group invested in early-stage biotech developing rare-disease therapies, often ahead of potential in-licensing or acquisition, as with its stake in Ultragenyx.

Shire is a Venture Capital firm based in Dublin, Ireland. It has made 2 investments, including Naurex and Ultragenyx Pharmaceutical Inc.. Focus areas include Biotech and Healthcare.

Portfolio2

Co-investors20

Sign up to view co-investors

20 co-investors across 20 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×11 · Corporate VC ×3 · Other ×2 · 15 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Shire on Indexed.vc
<a href="https://indexed.vc/investors/shire"><img src="https://indexed.vc/api/badge/investor/shire" alt="Shire on Indexed.vc" width="260" height="76" /></a>